S

S2Medical AB (publ)
STO:S2M

Watchlist Manager
S2Medical AB (publ)
STO:S2M
Watchlist
Price: 0.011 SEK -12% Market Closed
Market Cap: 10.8m SEK
Have any thoughts about
S2Medical AB (publ)?
Write Note

Intrinsic Value

S2M's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one S2M stock under the Base Case scenario is 0.03 SEK. Compared to the current market price of 0.011 SEK, S2Medical AB (publ) is Undervalued by 63%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

S2M Intrinsic Value
0.03 SEK
Undervaluation 63%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation Backtest
S2Medical AB (publ)

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for S2M cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about S2M?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about S2Medical AB (publ)

Provide an overview of the primary business activities
of S2Medical AB (publ).

What unique competitive advantages
does S2Medical AB (publ) hold over its rivals?

What risks and challenges
does S2Medical AB (publ) face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for S2Medical AB (publ).

Provide P/S
for S2Medical AB (publ).

Provide P/E
for S2Medical AB (publ).

Provide P/OCF
for S2Medical AB (publ).

Provide P/FCFE
for S2Medical AB (publ).

Provide P/B
for S2Medical AB (publ).

Provide EV/S
for S2Medical AB (publ).

Provide EV/GP
for S2Medical AB (publ).

Provide EV/EBITDA
for S2Medical AB (publ).

Provide EV/EBIT
for S2Medical AB (publ).

Provide EV/OCF
for S2Medical AB (publ).

Provide EV/FCFF
for S2Medical AB (publ).

Provide EV/IC
for S2Medical AB (publ).

Compare the intrinsic valuations
of S2Medical AB (publ) and its key competitors using the latest financial data.

Compare historical revenue growth rates
of S2Medical AB (publ) against its competitors.

Analyze the profit margins
(gross, operating, and net) of S2Medical AB (publ) compared to its peers.

Compare the P/E ratios
of S2Medical AB (publ) against its peers.

Discuss the investment returns and shareholder value creation
comparing S2Medical AB (publ) with its peers.

Analyze the financial leverage
of S2Medical AB (publ) compared to its main competitors.

Show all profitability ratios
for S2Medical AB (publ).

Provide ROE
for S2Medical AB (publ).

Provide ROA
for S2Medical AB (publ).

Provide ROIC
for S2Medical AB (publ).

Provide ROCE
for S2Medical AB (publ).

Provide Gross Margin
for S2Medical AB (publ).

Provide Operating Margin
for S2Medical AB (publ).

Provide Net Margin
for S2Medical AB (publ).

Provide FCF Margin
for S2Medical AB (publ).

Show all solvency ratios
for S2Medical AB (publ).

Provide D/E Ratio
for S2Medical AB (publ).

Provide D/A Ratio
for S2Medical AB (publ).

Provide Interest Coverage Ratio
for S2Medical AB (publ).

Provide Altman Z-Score Ratio
for S2Medical AB (publ).

Provide Quick Ratio
for S2Medical AB (publ).

Provide Current Ratio
for S2Medical AB (publ).

Provide Cash Ratio
for S2Medical AB (publ).

What is the historical Revenue growth
over the last 5 years for S2Medical AB (publ)?

What is the historical Net Income growth
over the last 5 years for S2Medical AB (publ)?

What is the current Free Cash Flow
of S2Medical AB (publ)?

Discuss the annual earnings per share (EPS)
trend over the past five years for S2Medical AB (publ).

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
S2Medical AB (publ)

Current Assets 5.1m
Cash & Short-Term Investments 1.4m
Receivables 1.7m
Other Current Assets 2m
Non-Current Assets 12.6m
PP&E 575k
Intangibles 12m
Other Non-Current Assets 1k
Current Liabilities 7.5m
Accounts Payable 1.1m
Accrued Liabilities 2.7m
Other Current Liabilities 3.8m
Efficiency

Earnings Waterfall
S2Medical AB (publ)

Revenue
10.6m SEK
Cost of Revenue
-1.1m SEK
Gross Profit
9.5m SEK
Operating Expenses
-7.3m SEK
Operating Income
2.2m SEK
Other Expenses
-4.1m SEK
Net Income
-1.9m SEK

Free Cash Flow Analysis
S2Medical AB (publ)

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

S2M Profitability Score
Profitability Due Diligence

S2Medical AB (publ)'s profitability score is 32/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 1-Year Revenue Growth
ROE is Increasing
ROIC is Increasing
32/100
Profitability
Score

S2Medical AB (publ)'s profitability score is 32/100. The higher the profitability score, the more profitable the company is.

S2M Solvency Score
Solvency Due Diligence

S2Medical AB (publ)'s solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
36/100
Solvency
Score

S2Medical AB (publ)'s solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

S2M Price Targets Summary
S2Medical AB (publ)

There are no price targets for S2M.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for S2M?

Click here to dive deeper.

Dividends

S2Medical AB (publ)
does not pay dividends
Shareholder Yield

Current shareholder yield for S2M is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

S2Medical AB (publ)

Country

Sweden

Industry

Health Care

Market Cap

12.2m SEK

Dividend Yield

0%

Description

S2Medical AB engages in research and development in biotechnology. The company is headquartered in Linkoping, Ostergotland. The company went IPO on 2018-11-28. The firm focuses on developing products for healing burns and chronic wounds, from debridement and granulation to reepithelialization. The firm's product portfolio includes INSTAQRETT, a sterile single-use mechanical debridement tool, the Epiprotect product line based on its collagen-mimicking Eiratex material, which includes EPIPROTECT Safestop, a blood-stilling membrane dressing, EPIPROTECT 2117, a synthetic substitute to allografts and xenografts, EPIPROTECT ULCER, dressing for treating ulcers, as well as INSTABIND bandages and Instagraft, a single-use medical device designed to treat chronic wounds with microtransplants from the patient's own skin without creating any new wounds. The firm is also the official distributor of Silverlon antimicrobial dressings for Nordic countries. In addition, it operates the S2Clinic, a wound healing center in Sweden.

Contact

OSTERGOTLAND
Linkoping
Sunnorpsgatan 5
+4687000050
www.s2m.se

IPO

2018-11-28

Employees

-

Officers

Co-Founder & CEO
Mr. Petter Sivlér
Co-Founder, COO & Director
Mr. MĂĄrten Skog

See Also

Discover More
What is the Intrinsic Value of one S2M stock?

The intrinsic value of one S2M stock under the Base Case scenario is 0.03 SEK.

Is S2M stock undervalued or overvalued?

Compared to the current market price of 0.011 SEK, S2Medical AB (publ) is Undervalued by 63%.

Back to Top